Beyond the presence of autoantibodies to p53, and despite the presence of autoantibodies to p63 and p73 in the sera of cancer patients’ non-seroreactive to p53, the study of the roles of p63 and p73 autoantibodies in cancer have been almost dismissed18–22. The gene discussed is TP53; the disease is cancer.